Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADCT
#2941
ADC Therapeutics SA
3.8
9
USD
+0.26%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.26%
Mudança mensal
-7.82%
Mudança em 6 meses
-7.82%
Mudança anual
+224.17%
Fechamento anterior
3.8
8
Abrir
3.9
0
Bid
Ask
Mínimo
3.8
8
High
3.9
2
Volume
69
Mercados
Ações
Cuidados de saúde
ADCT
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
76.72 M
76.81 M
80.64 M
82.53 M
99.08 M
127.04 M
—
Valuation ratios
Enterprise value
2.02 B
1.09 B
-36.93 M
-14.75 M
69.31 M
304.2 M
903.57 M
Price to earnings ratio
—
—
—
-0.57
-1.23
-3.15
-8.7
Price to sales ratio
—
—
—
1.99
2.73
5.51
17
Price to cash flow ratio
—
—
—
-1.16
-1.56
-3.18
-9.86
Price to book ratio
—
—
—
-0.93
-0.95
-2.41
-3.47
Enterprise value to EBITDA ratio
-9.24
-4.14
0.29
-7.03
0.42
6.59
1.69
Profitability ratios
Return on assets %
-0.48
-0.37
-0.29
-0.68
-0.49
-0.44
-0.48
Return on equity %
-0.73
-1.38
-1.76
1.62
0.78
0.77
0.65
Return on invested capital %
—
—
—
-3 974.11
-3 028.63
-2 845.4
-7 417.58
Gross margin %
—
-4.11
-2.18
96.36
91.6
92.87
389.29
Operating margin %
—
-771.65
-58.9
-238.63
-184.44
-149.34
-624.16
EBITDA margin %
—
-772.66
-60.43
28.45
-182.46
34.91
-153.27
Net margin %
—
-678.2
-74.22
-345.11
-222.83
-175.31
-745.46
Liquidity ratios
Quick ratio
—
6.95
4.32
4.73
3.59
4.31
17.47
Current ratio
11.14
7.1
4.51
4.97
3.82
4.37
18.39
Inventory turnover
—
0.13
0.31
0.09
0.09
0.2
0.14
Asset turnover
0
0.06
0.37
0.16
0.21
0.25
0.27
Solvency ratios
Debt to assets ratio
—
—
—
0.35
0.38
0.36
1.58
Debt to equity ratio
—
—
—
-0.84
-0.61
-0.63
-2.22
Long term debt to total assets ratio
—
—
—
0.32
0.35
0.36
1.53
Long term debt to total equity ratio
—
—
—
-0.76
-0.56
-0.62
-2.16
Per share metrics
Operating cash flow per share
—
—
—
-1.45
-1.27
-1.11
-1.2
EBIT per share
—
—
—
-2.03
-1.34
-0.96
-1.02
EBITDA per share
—
—
—
0.24
-1.33
0.22
-0.35
Total debt per share
—
—
—
1.52
1.27
0.92
3.95
Cash per share
—
—
—
3.41
2.58
2.06
7.92
Net current asset value per share
—
—
—
4.12
3.16
2.41
9.72
Tangible book value per share
—
—
—
-1.81
-2.09
-1.46
-7.18
Working capital per share
—
—
—
3.29
2.34
1.86
7.61
Book value per share
—
—
—
-1.81
-2.09
-1.46
-7.18
Notícias
ADC Therapeutics na H.C. Wainwright: foco estratégico em ZYNLONTA
H.C. Wainwright eleva preço-alvo das ações da ADC Therapeutics para US$ 8
ADC Therapeutics SA 2025 Q4 - Results - Earnings Call Presentation (NYSE:ADCT) 2026-03-11
Micron and BioNTech among market cap stock movers on Tuesday
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
Lucro da Adc Thera superou projeções por $0,20; receita supera estimativas
Adc Thera earnings beat by $0.20, revenue topped estimates
ADC Therapeutics reporta receita de US$ 22,3 milhões no quarto trimestre
ADC Therapeutics reports Q4 revenue of $22.3 million
ADC Therapeutics entrega retorno de 70% ao atingir meta de preço-justo
ADC Therapeutics delivers 70% return as Fair Value target hit
ADC Therapeutics apresenta expansão estratégica no tratamento de linfoma